Under construction – not a live service
Sign in
Taking peopleNo phase

Analysis of Trunk and Center of Mass Control Development During Gait in Children With Cerebral Palsy (VERTEBRAL)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Trial code
NCT06320288
Record updated
12 January 2026
Original description
During the acquisition of posturokinetic abilities such as walking, postural control of the trunk is of paramount importance. Indeed, its development is strongly linked to the overall motor function of children. In cerebral palsy (CP), a term that refers to a set of motor disorders following a perinatal lesion, deficits in axial control are present from early childhood. These deficits are strongly correlated with the functional deficits observed in this population. In particular, during walking, deviations of the trunk (amplitudes, accelerations) are observed in the three planes of space. While recent literature increasingly questions the impact of trunk control deficit on the walking of children with CP, elements are still missing for a holistic understanding of the interaction between locomotor and postural disorders in children with CP. In particular, no study has focused on the deviations of trunk control and the center of mass (which is a global indicator of balance strategies) during the development and maturation of walking in children with CP. Therefore, the primary objective of this cross-sectional observational study will be to characterize the development of trunk control and center of mass during walking in children with CP.Read full original descriptionShow less

Analysis of Trunk and Center of Mass Control Development During Gait in Children With Cerebral Palsy

During the acquisition of posturokinetic abilities such as walking, postural control of the trunk is of paramount importance. Indeed, its development is strongly linked to the overall motor function of children. In cerebral palsy (CP), a term that refers to a set of motor disorders following a perinatal lesion, deficits in axial control are present from early childhood. These deficits are strongly correlated with the functional deficits observed in this population. In particular, during walking, deviations of the trunk (amplitudes, accelerations) are observed in the three planes of space. While recent literature increasingly questions the impact of trunk control deficit on the walking of children with CP, elements are still missing for a holistic understanding of the interaction between locomotor and postural disorders in children with CP. In particular, no study has focused on the deviations of trunk control and the center of mass (which is a global indicator of balance strategies) during the development and maturation of walking in children with CP. Therefore, the primary objective of this cross-sectional observational study will be to characterize the development of trunk control and center of mass during walking in children with CP.

Inclusion: Children (< 18 years) with cerebral palsy; GMFCS I to III; Independent walking with or without technical walking aids (walker, crutches, etc.); Able to understand the instructions of various clinical assessments and functional explorations; Affiliated with a social security scheme.

Exclusion: Neuro-orthopaedic surgery of the lower limbs or trunk within the last 12 months; Surgery on lower limbs or trunk last 12 months; Children with cerebral palsy; Botulinum toxin A injections within the last 6 months; Therapeutic intervention targeting trunk control last 6 months; Typically developing children; Neurological and/or orthopedic pathology that may influence gait.

ClinicalTrials.gov NCT06320288